Literature DB >> 7269556

Penile revascularization in the treatment of impotence.

I D Sharlip.   

Abstract

New clinical developments in the diagnosis and treatment of male sexual dysfunction have occurred in the past several years. Much of this information has not been disseminated to the general medical public. Of particular note, a series of reliable penile prosthetic devices for the treatment of advanced erectile dysfunction is now considered to be established and valid surgical therapy. The new diagnostic techniques of nocturnal penile tumescence monitoring, penile plethysmography, penile sphygmomanometry and phalloarteriography are beginning to show that some patients with erectile impotence have arteriosclerosis of the penile arteries. These patients were formerly considered to have psychogenic or idiopathic impotence. Some of these patients with vasculogenic impotence may benefit from the new surgical technique of penile revascularization, thus obviating the need for penile prosthetic implants.A preliminary report of a small series of cases of corpus cavernosum revascularization using the microsurgical implantation of the inferior epigastric artery directly into the corpus cavernosum with prolonged systemic anticoagulation gives a cure/improvement rate of 40 percent. Better selection of patients for operation and perfection of surgical technique offer the chance for improvement in this rate of success. The proper role of corpus cavernosum revascularization in the treatment of impotence remains to be clearly defined. However, these preliminary results, coupled with several reports from Europe, are sufficiently encouraging to justify continued clinical investigation and surgical experience with penile revascularization for vasculogenic impotence.

Entities:  

Mesh:

Year:  1981        PMID: 7269556      PMCID: PMC1272604     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  9 in total

1.  A history of surgical treatment of impotence.

Authors:  W F Gee
Journal:  Urology       Date:  1975-03       Impact factor: 2.649

2.  [Arteriography of internal pudendal arteries and revascularization of the corpus cavernosum in impotence of vascular etiology].

Authors:  J Ginestié; J F Ginestié; A Romieu
Journal:  J Urol Nephrol (Paris)       Date:  1976

3.  [The treatment of impotence of vascular origin. Revascularisation of the corpora cavernosa].

Authors:  J Ginestié; A Romieu
Journal:  J Urol Nephrol (Paris)       Date:  1976 Oct-Nov

4.  Arterial epigastricocavernous anastomosis for the treatment of sexual impotence.

Authors:  V Michal; R Kramár; J Pospíchal; L Hejhal
Journal:  World J Surg       Date:  1977-07       Impact factor: 3.352

5.  Penile blood pressure in the evaluation of erectile impotence.

Authors:  G Engel; S J Burnham; M F Carter
Journal:  Fertil Steril       Date:  1978-12       Impact factor: 7.329

6.  Morphologic changes in the arterial bed of the penis with aging. Relationship to the pathogenesis of impotence.

Authors:  V Ruzbarský; V Michal
Journal:  Invest Urol       Date:  1977-11

7.  Erectile impotence treated with an implantable, inflatable prosthesis. Five years of clinical experience.

Authors:  F B Scott; G J Byrd; I Karacan; P Olsson; L E Beutler; S L Attia
Journal:  JAMA       Date:  1979-06-15       Impact factor: 56.272

8.  Revascularization of corpus cavernosum for erectile failure.

Authors:  W C Casey
Journal:  Urology       Date:  1979-08       Impact factor: 2.649

9.  Impotence caused by pudendal arteriovenous fistula.

Authors:  A W Zorgniotti; G Padula; G Rossi
Journal:  Urology       Date:  1979-08       Impact factor: 2.649

  9 in total
  2 in total

1.  The history of microsurgery in urology.

Authors:  Alexander W Pastuszak; Evan P Wenker; Larry I Lipshultz
Journal:  Urology       Date:  2015-05       Impact factor: 2.649

2.  Survey of Microsurgery Training Availability in US Urology Residency Programs.

Authors:  Thomas A Masterson; Sirpi Nackeeran; Quinn Rainer; Nicholas Hauser; Robert Marcovich; Ranjith Ramasamy
Journal:  World J Mens Health       Date:  2020-05-18       Impact factor: 5.400

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.